Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-16-009836
Filing Date
2016-04-18
Accepted
2016-04-18 15:10:52
Documents
28
Period of Report
2016-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mixx_10q.htm 10-Q 205790
2 CERTIFICATION mixx_ex311.htm EX-31.1 7396
3 CERTIFICATION mixx_ex312.htm EX-31.2 7480
4 CERTIFICATION mixx_ex321.htm EX-32.1 3878
5 CERTIFICATION mixx_ex322.htm EX-32.2 3748
12 img001.jpg GRAPHIC 31152
13 img002.jpg GRAPHIC 19891
14 img003.jpg GRAPHIC 41620
15 img004.jpg GRAPHIC 27064
  Complete submission text file 0001477932-16-009836.txt   974561

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mixx-20160229.xml EX-101.INS 41296
7 XBRL TAXONOMY EXTENSION SCHEMA mixx-20160229.xsd EX-101.SCH 10596
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mixx-20160229_cal.xml EX-101.CAL 33725
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mixx-20160229_def.xml EX-101.DEF 4444
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mixx-20160229_lab.xml EX-101.LAB 94867
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mixx-20160229_pre.xml EX-101.PRE 61446
Mailing Address 16000 N. 80TH STREET SUITE E SCOTTSDALE AZ 85260
Business Address 16000 N. 80TH STREET SUITE E SCOTTSDALE AZ 85260 480-371-1100
MIX 1 LIFE, INC. (Filer) CIK: 0001501112 (see all company filings)

EIN.: 680678499 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-55422 | Film No.: 161576771
SIC: 2834 Pharmaceutical Preparations